USMLE Step 1 Psychiatry High-Yield Facts

Psychiatry questions on USMLE Step 1 are notoriously high-yield, often presented as clinical vignettes that test your diagnostic acumen and treatment knowledge. A solid grasp of key disorders, their neurobiological underpinnings, and first-line interventions is essential for maximizing your score. This guide consolidates the must-know facts and strategies to tackle these questions with confidence.

Diagnostic Criteria and Key Features of Major Disorders

Your first task in any psychiatry vignette is accurate diagnosis, which hinges on recognizing hallmark symptoms. Mood disorders are characterized by pervasive emotional disturbances. Major depressive disorder (MDD) requires at least two weeks of depressed mood or anhedonia, plus associated symptoms like sleep changes, guilt, or suicidal ideation. Bipolar disorder involves manic episodes—distinct periods of elevated, expansive, or irritable mood with increased activity—often alternating with depression. First-line treatment for MDD is an SSRI, while mood stabilizers like lithium or valproate are cornerstone for bipolar disorder.

Anxiety disorders share excessive fear and anxiety but differ in focus. Generalized anxiety disorder (GAD) features chronic, uncontrollable worry about multiple events. Panic disorder involves recurrent, unexpected panic attacks followed by persistent concern. Obsessive-compulsive disorder (OCD) is defined by obsessions (intrusive thoughts) and compulsions (repetitive behaviors), with SSRIs at high doses and cognitive-behavioral therapy as first-line. Post-traumatic stress disorder (PTSD) requires exposure to trauma, followed by intrusive symptoms, avoidance, negative alterations in cognition/mood, and hyperarousal.

Psychotic disorders center on reality distortion. Schizophrenia requires at least six months of symptoms, including positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., flat affect, avolition). Schizoaffective disorder combines a major mood episode with psychotic symptoms that persist for at least two weeks without mood symptoms. First-line treatment for psychosis is an atypical antipsychotic like risperidone or olanzapine.

Personality disorders are enduring, inflexible patterns causing impairment, grouped into three clusters. Cluster A (odd/eccentric) includes paranoid, schizoid, and schizotypal. Cluster B (dramatic/emotional) encompasses antisocial, borderline, histrionic, and narcissistic. Cluster C (anxious/fearful) contains avoidant, dependent, and obsessive-compulsive personality disorders. Diagnosis often relies on longitudinal history, as these patterns are pervasive.

Substance use disorders involve a problematic pattern of use leading to impairment. Key substances for Step 1 include alcohol, opioids, stimulants (cocaine, amphetamines), and sedatives. Know withdrawal syndromes: alcohol withdrawal can cause tremors, hallucinations, and seizures, treated with benzodiazepines; opioid withdrawal features flu-like symptoms, managed with taper or methadone/buprenorphine. Intoxication and withdrawal timelines are frequently tested.

Neurotransmitter Pathways and Psychopharmacology

Understanding neurotransmitter associations is crucial for linking pathology to pharmacology. The monoamine hypothesis ties depression to deficits in serotonin, norepinephrine, and dopamine. Anxiety disorders often involve GABA (inhibitory) and norepinephrine (excitatory) systems. Psychosis is strongly associated with dopamine hyperactivity in the mesolimbic pathway, particularly D2 receptor overactivity.

Psychiatric medication side effects are high-yield. SSRIs (e.g., fluoxetine) can cause sexual dysfunction, insomnia, and serotonin syndrome—a triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities. SNRIs (e.g., venlafaxine) add noradrenergic effects like hypertension. Typical antipsychotics (e.g., haloperidol) carry high risk of extrapyramidal symptoms (EPS): acute dystonia, akathisia, parkinsonism, and tardive dyskinesia. Atypical antipsychotics (e.g., olanzapine) have lower EPS risk but can cause metabolic syndrome (weight gain, diabetes). Mood stabilizers: lithium requires monitoring for nephrotoxicity, hypothyroidism, and teratogenicity; valproate causes hepatotoxicity and neural tube defects. Benzodiazepines (e.g., lorazepam) risk dependence, sedation, and respiratory depression.

Psychological Concepts: Defense Mechanisms

Defense mechanisms are unconscious psychological strategies to manage anxiety. Recognizing them in vignettes can clue you into personality styles or stress responses. Mature defenses, like sublimation (channeling impulses into socially acceptable activities) and humor, are adaptive. Neurotic defenses include repression (pushing distressing thoughts into the unconscious) and displacement (redirecting emotions to a safer target). Immature defenses, such as projection (attributing one’s own unacceptable feelings to others) and denial (refusing to acknowledge reality), are common in personality disorders and substance use. For example, a patient blaming others for their failures might be using projection, often seen in paranoid personality.

Eating Disorders and Sleep Disorders

Eating disorders involve severe disturbances in eating behavior. Anorexia nervosa features restriction of energy intake leading to significantly low body weight, intense fear of gaining weight, and disturbed body image. Bulimia nervosa involves recurrent binge-eating followed by inappropriate compensatory behaviors (e.g., vomiting, laxatives) without severe weight loss. Binge-eating disorder has binges without compensatory behaviors. Medical complications like electrolyte imbalances and cardiac issues are critical for Step 1.

Sleep disorders are tested on pathophysiology and presentation. Insomnia is difficulty initiating or maintaining sleep. Narcolepsy involves excessive daytime sleepiness with cataplexy (sudden loss of muscle tone), linked to loss of hypocretin-producing neurons. Obstructive sleep apnea features repeated apneas due to airway obstruction, leading to daytime fatigue and cardiovascular risk. Parasomnias like sleepwalking (somnambulism) occur during NREM sleep, while REM sleep behavior disorder involves acting out dreams due to lack of muscle atonia.

Strategies for Psychiatry Vignettes on Step 1

Approach each psychiatry question methodically. First, identify the chief complaint and timeline—acute versus chronic symptoms often differentiate disorders (e.g., schizophrenia vs. brief psychotic disorder). Second, rule out medical causes: always consider substance use, endocrine disorders (e.g., hypothyroidism mimicking depression), or neurological conditions before settling on a primary psychiatric diagnosis. Third, match the symptom cluster to diagnostic criteria, paying attention to specifiers like “with psychotic features” in depression.

For treatment questions, recall first-line interventions: SSRIs for most anxiety and depressive disorders, atypical antipsychotics for psychosis, mood stabilizers for bipolar, and CBT for many conditions. Highlight trap answers: avoiding benzodiazepines as first-line for PTSD due to addiction risk, or recognizing that antipsychotics are not first-line for OCD unless with comorbid psychosis. Practice by asking yourself: “What is the most urgent issue?” For example, in a suicidal patient, hospitalization trumps medication selection in the answer choices.

Common Pitfalls

1. Misdiagnosing bipolar disorder as major depression: A patient presenting with depression might have underlying bipolar disorder. Starting an antidepressant without a mood stabilizer can precipitate mania. Always screen for past manic or hypomanic episodes in depressive presentations.

1. Overlooking medication side effects: In a vignette, new symptoms after starting a drug might be side effects, not a separate illness. For instance, akathisia from antipsychotics can be mistaken for anxiety or agitation. Know classic side effect profiles to avoid this trap.

1. Confusing psychosis etiologies: Psychotic symptoms can arise from mood disorders, substance use, or medical conditions. Schizophrenia requires a chronic course with functional decline. Don’t jump to schizophrenia without ruling out schizoaffective disorder (mood episode required) or substance-induced psychosis.

1. Missing personality disorder cues: Personality disorders are often hinted at by chronic interpersonal difficulties and maladaptive patterns across situations. Ignoring this longitudinal context can lead to misdiagnosis as an axis I disorder like depression.

Summary

• Diagnosis is key: Master the DSM-5 criteria for mood, anxiety, psychotic, personality, and substance use disorders, focusing on distinguishing features.
• Neurotransmitters guide treatment: Associate serotonin with depression/anxiety, dopamine with psychosis, and GABA with anxiety; know first-line medications and their major side effects.
• Defense mechanisms reveal coping styles: Recognize common mechanisms like projection, denial, and displacement to inform personality assessments.
• Eating and sleep disorders have specific criteria: Anorexia involves low weight, bulimia involves bingeing/purging; narcolepsy includes cataplexy, sleep apnea features obstruction.
• Vignette strategy: Rule out medical/substance causes, match symptoms to criteria, and select first-line treatments while avoiding common traps like precipitating mania.
• Pitfalls to avoid: Don’t miss bipolarity in depression, attribute new symptoms to side effects, confuse psychosis types, or overlook chronic patterns in personality disorders.